The opening price for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) was $28.6 and the volume amounted to 1.72 million shares which compares with the average volume of 1.58 million shares. The company stock experienced a -2.55% move to arrive at $27.9.ACADIA Pharmaceuticals Inc. (ACAD) Analyst Opinion
ACADIA Pharmaceuticals Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 8.07% of shares outstanding. The stock sank -6.91% last month and is down -7.34 this year. Wall Street is only getting more bullish on the stock, with 8 of analysts who cover ACAD having a buy-equivalent rating. Analysts have placed a $49.78 price target on ACADIA Pharmaceuticals Inc., suggesting a 78.42% gain from recent close. It’s currently trading about -32.28% below its 52-week high.ACADIA Pharmaceuticals Inc. Earnings Surprise
ACADIA Pharmaceuticals Inc. (ACAD) surprised the stock market in its last reported earnings when it earned -$0.53 a piece versus the consensus-estimated -$0.62. Its revenue totaled $32.03 million up 5.09% from the previous quarter.ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Intraday View
This stock (ACAD) is ahead of its 52-week low with 11.33%. Its last month’s stock price volatility remained 4.79% which for the week stands at 3.91%. The share price has moved backward from its 20 days moving average, trading at a distance of -4.46% and stays -5.99% away from its 50 days moving average. Over the last five days, shares have faced -3.06% losses and now is down -11.19% since hitting its 200-day moving average of $31.94. ACADIA Pharmaceuticals Inc. (ACAD) has made its way to a 12-month decline of -6.6%.
Turning to e.l.f. Beauty, Inc. (NYSE:ELF), its shares were trading at $19.72 a gain of $0.55, on the trading floor. The stock, after opening at $18.99, touched a high of $19.73 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.2. e.l.f. Beauty, Inc. has 4 buy ratings, 5 holds and 0 sells even after the stock tumbled -36.59% from its high of $31.10 to a $895.09 million market value through last close.e.l.f. Beauty, Inc. (ELF) Consensus Price Target
The company’s consensus rating on Reuter’s scale improved from 2.08 to 2.23 during a month. Analysts set a 12-month price target of $22.27 a share. The target implies a 12.93% spike from where the shares are currently trading. Also, the current price highlights a discount of 31.85% to analysts’ high consensus price target.e.l.f. Beauty, Inc. (NYSE:ELF) Intraday Trading
The counter witnessed a trading volume of 1.15 million shares versus an average volume of 0.51 million shares during last trading session. Its last month’s stock price volatility remained 5.38% which for the week approaches 4.14%. The lowest price the stock reached in the last trading day was $18.83 and compares with the $18.52 52-week low. The stock recovered 6.48% since its low point and has performed -11.61% year-to-date.